Xu L, Sun H-B, Xu Z-N, Han X-L, Yin Y-Y, Zheng Y, Zhao Y, Wang Z-X
Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):2827. doi: 10.26355/eurrev_202104_25529.
The article "MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1, by L. Xu, H.-B. Sun, Z.-N. Xu, X.-L. Han, Y.-Y. Yin, Y. Zheng, Y. Zhao, Z.-X. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (18): 7978-7988-DOI: 10.26355/eurrev_201909_19014-PMID: 31599423" has been withdrawn from the authors due to some technical reasons (there are some errors and incorrect data). The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19014.
文章《MicroRNA-218通过直接靶向BMI-1调控上皮-间质转化和PI3K/Akt信号通路以抑制肺腺癌进展》，作者为L. Xu、H.-B. Sun、Z.-N. Xu、X.-L. Han、Y.-Y. Yin、Y. Zheng、Y. Zhao、Z.-X. Wang，发表于《欧洲医学与药理学综述》2019年；23(18): 7978 - 7988 - DOI: 10.26355/eurrev_201909_19014 - PMID: 31599423，因一些技术原因（存在一些错误和不正确的数据）已被作者撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19014
